familial Mediterranean fever (4)
rheumatoid arthritis (4)
Ankylosing spondylitis (3)
M694V (3)
axial spondyloarthritis (2)
Familial Mediterranean fever (2)
inflammation (2)
periodontitis (2)
psoriasis (2)
psoriatic arthritis (2)
Rheumatoid arthritis (2)
saliva (2)
Vitamin D (2)
ACE I/D (1)
Acute lymphoblastic leukemia (1)
acute phase response reactants (1)
adiponectin (1)
Adult rheumatic disease (1)
Adult rheumatic disease | axial spondyloarthritis | extra-muskuloskeletal manifestations | peripheral manifestations (1)
Adult-onset Still's disease (1)
adverse event (1)
adverse event | biologic DMARDs | chronic kidney disease | safe use | spondylarthritis (1)
age at onset of disease (1)
ALL (1)
Ambulatory blood pressure monitoring (1)
AML (1)
amyloidosis (1)
Anemia | bone formation | metabolism | nutrition | vitamins (1)
ankilozan spondilartrit | cardiovascular diseases | Klotho | plasma atherogenic index | SCORE (1)
Ankylosing Spondylitis (1)
Ankylosing spondylitis | anterior uveitis | orbital Doppler ultrasonography (1)
Ankylosing spondylitis | Atherosclerosis | Carotid intima-media thickness | Klotho | Salusin-α (1)
Ankylosing Spondylitis | C-reactive protein albumin ratio | platelet albumin ratio | systemic inflammation index (1)
Ankylosing spondylitis | inter-observer agreement | magnetic resonance imaging (1)
Ankylosing spondylitis | myelin oligodendrocyte glycoprotein antibody disease | optic neuritis (1)
ankylosing spondylitis | Ochronosis | sacroiliac joint (1)
anterior uveitis (1)
Anti-cyclic citrullinated peptide (1)
anti-nuclear antibody (1)
anti-thyroid antibody (1)
Arthritis | Interferon-gamma release tests | Latent tuberculosis | Spondyloarthritis | Tuberculin test (1)
Atherosclerosis (1)
atopy (1)
Autoimmune thyroid disease (1)
axial spondyloarthritis | bamboo spine | body mass index | enthesitis | hip arthritis (1)
bamboo spine (1)
BASDAI (1)
Behcet's disease (1)
Bilaterality (1)
biologic agents (1)
biologic agents | paradoxical reactions | predictors | psoriasis | TNF-alpha inhibitors (1)
biologic DMARDs (1)
biological drugs (1)
Biological drugs | Drug retention | Real life data | Rheumatoid arthritis | Tocilizumab (1)
bleeding (1)
body mass index (1)
bortezomib (1)
Carbon monoxide diffusion capacity | Interstitial lung disease | Rheumatoid arthritis | Spirometric function tests (1)
cardiac failure (1)
chronic kidney disease (1)
Connective tissue (1)
continuous passive motion (1)
contrast media (1)
contrast media | contrast-induced nephropathy | inflammation | kidney injury | reactive oxygen species (1)
contrast-induced nephropathy (1)
COVID-19 (1)
COVID-19 | Mortality | Pandemic | Psoriatic arthritis (1)
cup-like blast (1)
Cyclophosphamide (1)
disease activity (1)
Disease modifying anti-rheumatic drugs (1)
Disease pattern (1)
drug retention (1)
E148Q (1)
early and late-onset (1)
early disease (1)
early onset (1)
enthesitis (1)
Essential thrombocythemia (1)
exon 10 (1)
exon 2 (1)
extra-muskuloskeletal manifestations (1)
Felty syndrome (1)
femoral cartilage thickness (1)
FLT3 ITD (1)
frozen shoulder (1)
Gastrointestinal (1)
gren syndrome (1)
Heat shock protein 90 (1)
Hepatitis C virus (1)
hip arthritis (1)
Hydroxychloroquine | Hydroxychloroquine | Leflunomide | Léflunomide | Methotrexate | Méthotrexate | Ocular surface | Polyarthrite rhumatoïde | Rheumatoid arthritis | Surface oculaire (1)
Hypereosinophilic syndrome (1)
Hypertension (1)
Immunoglobulin A (1)
Immunohistochemical staining (1)
inception cohort (1)
innate immunity (1)
insulin resistance (1)
kidney injury (1)
Leukocytosis (1)
Lower urinary tract symptoms (1)
Lower urinary tract symptoms | Neuropathic pain | Primary Sjögren syndrome (1)
lupus anticoagulant (1)
lymphoma (1)
Malignancy (1)
Mediterranean fever gene mutations (1)
Mortality (1)
Multifocality (1)
myelin oligodendrocyte glycoprotein antibody disease (1)
myeloma (1)
Neuropathic pain (1)
neutropenia (1)
Nocturnal fall in blood pressure (1)
Nocturnal hypertension (1)
Non-autoimmune thyrotoxicosis (1)
optic neuritis (1)
orbital Doppler ultrasonography (1)
PAI-1 4G/5G (1)
Pandemic (1)
Papillary thyroid cancer (1)
paradoxical reactions (1)
periodontitis | protease | rheumatoid arthritis | saliva | serum (1)
peripheral manifestations (1)
physical therapy (1)
Polycythemia vera (1)
predictors (1)
Pregnancy (1)
prevalence (1)
Primary Sj & ouml (1)
protease (1)
proteasome inhibitors (1)
Psoriatic arthritis (1)
reactive oxygen species (1)
real life data (1)
Remission (1)
Renal stone (1)
Rheumatoid factor (1)
safe use (1)
Scleroderma (1)
serum (1)
Shoulder pain (1)
spondylarthritis (1)
Survival (1)
systemic disease (1)
Systemic sclerosis (1)
Thrombosis (1)
TNF-alpha inhibitors (1)
tocilizumab (1)
trombosis (1)
Turkey (1)
ultrasonography (1)
Urolithiasis (1)
Vascular endothelial growth factor (1)
Werner's syndrome (1)